Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Groot, S. de
(-)
= Guchelaar, H.J.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(4)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(4)
+
-
Creation Date
2016
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(5)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(5)
+
-
Author
Groot, S. de
(5)
+
-
Gelderblom, H.
(4)
+
-
Kroep, J.R.
(4)
+
-
Charehbili, A.
(3)
+
-
Pijl, H.
(3)
+
-
Straaten, T. van der
(3)
+
-
Swen, J.J.
(3)
+
-
Baak-Pablo, R.
(2)
+
-
Bohringer, S.
(2)
+
-
Dekker-Ensink, N.G.
(2)
+
-
Heijns, J.B.
(2)
+
-
Hoeven, J.J.M. van der
(2)
+
-
Houtsma, D.
(2)
+
-
Janssen, L.G.M.
(2)
+
-
Kessels, L.W.
(2)
+
-
Laarhoven, H.W.M. van
(2)
+
-
Mooyaart, A.L.
(2)
+
-
Smit, V.T.H.B.M.
(2)
+
-
Velde, C.J.H. van de
(2)
+
-
Ven, S. van de
(2)
+
-
Show more
Language
en
(5)
+
-
Search results
(1 - 5 of 5)
show grid
show list
save search
The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival
Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01)
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia
Variation in the ESR-1 gene as a prognostic marker in early breast cancer survival